Notably, EGFRvIII and PIK3CA mutations were exclusively found in GPC1 tumors, whereas other GBM driver mutations in TP53, NF1, PTEN, RB1, and EGFR (non-vIII) were relatively evenly distributed between the two subtypes (Fig. 2d). This evidence concerns the gene GPC1 and glioblastoma.